Generic drugs row settled

The Department of Health has announced a joint settlement with Goldshield (Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited) over claims brought against the company for allegedly attempting to price fix in an anti-competitive cartel when supplying generic drugs to the NHS.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here